GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) (Middle Region) Peptide
Quick Overview for GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) (Middle Region) Peptide (ABIN8101224)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- GABARAPL1 Peptide - middle region
-
Sequence
- VIVEKAPKAR VPDLDKRKYL VPSDLTVGQF YFLIRKRIHL RPEDALFFFV
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-GABARAPL1 Antibody (ARP58901_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
-
Background
- GABARAPL1 is a Ubiquitin-like modifier that increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor. it is involved in formation of autophagosomal vacuoles. Whereas LC3s are involved in elongation of the phagophore membrane, the GABARAP/GATE-16 subfamily is essential for a later stage in autophagosome maturation.
-
Molecular Weight
- 16kDa
-
Gene ID
- 23710
-
UniProt
- Q9H0R8
Target
-